Collectively, our data suggest that CH could be a powerful tool to counteract the amoeboid motility and the metastatic dissemination of melanoma cells by affecting the mitochondrial-mediated activation of AMPK and consequently blocking the RhoA/ROCK-dependent amoeboid phenotype. Here, RHOA is linked to melanoma.